This is a snippet of the transcript, sign up to read more.
Treatment packages differ at different centers. For example, RMA New Jersey requires you to biopsy all of the embryos before they transfer them. I don't know if any other center does that, but I do know RMA does. At the center I work for, genetic testing is an option if you choose to have it. It's an add-on.
This is a snippet of the transcript, sign up to read more.
If you're in a mandated state, you're going to see insurance. If you're in a non-mandated state, it's mostly private pay. For private pay patients, we offers internal financing, and patients can pay that way. There are also several outside options, like Future Family and CapexMD, which offer nice programs where you can pay within five years, etc. Each has unique features to differentiate themselves. For example, Future Family has a counselor to guide you along your journey, which sets them apart from other companies.
This is a snippet of the transcript, sign up to read more.
You have to have over 500 employees to be able to offer the fertility benefit. Those are the caveats. Once we get past all of those and they deem you have to offer the mandate, then you have to decide what you're going to cover. The state of Massachusetts in the United States has the best mandate. They cover six cycles of IVF from start to finish. Other states cover a specific amount of money, like $100,000 or $10,000, with lifetime access.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research